This antibody also demonstrated some synaptic α-synuclein staining, which implies that pS129 is a modification that occurs dominantly in pathological scenarios and may also be upregulated in synapses in MSA in agreement with the literature [39]. The gene discussed is SNCA; the disease is multiple system atrophy.